Protecting breakthrough ideas through patents, regulatory approvals, and technology commercialization.
Three patent filings protecting the core innovations of SIU BehaveNeu™ technology.
Claims an LSTM-CNN pipeline for classifying attention, stress, cognitive load, and fatigue from 8-channel EEG signals with >90% accuracy, optimized for edge deployment.
Covers a neurofeedback system that autonomously adapts protocol parameters (frequency band targets, feedback modality, session duration) based on individual response using RL algorithms.
Hardware patent covering the NeuroBand's dry electrode design, 24-bit ADC signal chain, adaptive noise cancellation circuit, and low-power BLE integration for medical-grade wearables.
SIU BehaveNeu™ NeuroBand has received regulatory clearance from the Central Drugs Standard Control Organisation (CDSCO) under the Medical Devices Rules, 2017 (MD-13) as a Class B medical device — a landmark achievement for Indian neurotechnology.
This approval validates the safety and efficacy of our EEG acquisition hardware and neurofeedback software for clinical use across India's healthcare system.
Regulatory approval for clinical-grade EEG neurotechnology device — making SIU BehaveNeu™ one of the first indigenous BCI products approved for healthcare use in India.
A Technology Transfer Agreement (TTA) was signed between Symbiosis International University and Nexactly AI Solutions Pvt. Ltd. in March 2024, enabling the commercialization of SIU BehaveNeu™ technology developed at SIT's Biomedical Engineering Lab.
Technology transfer from SIU to Nexactly; CDSCO approval received.
Consumer-grade NeuroBand with 16-channel EEG and redesigned app.
Distribution agreements with 10 hospitals and 3 corporate wellness chains.
Target ₹10Cr Series A from healthcare-focused VCs.
CE Mark obtained; SAARC region market entry with regional distribution.
FDA 510(k) clearance; US & EU market launch; B2B SaaS institutional model.
Technology development seed grant from Department of Science & Technology, National Initiative for Management of Ageing & Technology.
Biotechnology Industry Research Assistance Council (BIRAC) BIG grant for clinical validation and prototype development.
Internal SIU Innovation & Incubation Centre grant for lab infrastructure and team building.
Pre-Seed round from healthcare angel investors for commercialization, manufacturing scale-up, and market entry.
Targeting healthcare-focused VCs for product scale-up, international regulatory clearance, and market expansion.